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ABSTRACT
Objective: To determine the prevalence of  hepatitis B virus (HBV) markers in surgeons in
a major city in Nigeria.
Design: A cross-sectional, descriptive study.
Setting: Three major hospitals in Lagos, Nigeria.
Subjects: One hundred and sixty seven surgeons(study group)and l93 administrative
staff(controls).
Interventions: Blood samples were taken from subjects and analysed for hepatitis B virus
markers ( HBsAg, antiHBs and antiHBc) using the ELISA technique.
Main outcome measures: Hepatitis B virus marker sero-positivity
Results: The prevalence of  hepatitis B surface antigen (HBsAg) in the surgeons was found
to be 25.7% as compared to 15% in the control group (p=0.01). The frequency of antibody
to the surface antigen (antiHBs) was 22.2% among the surgeons and 4.1% in the control
group (p< 0.001) and that of antibody to the core antigen (antiHBc) was 61.7% in the
surgeons as compared to 53.4% in the control (p= 0.11). At least one HBV marker was found
in 76.6% of the surgeons as compared to 57% in the control group (p=0.0009).
Conclusion: Health care workers should be immunised against HBV. In Nigeria, HBV
immunisation should be considered for inclusion in the EPI.
INTRODUCTION
It is estimated that about one to two million people die
annually from HBV- related acute and chronic liver disease
worldwide(1).The majority of chronic carriers of HBV are
found in South East Asia and sub-Saharan Africa(2).
Twenty five per cent of carriers are at risk of chronic
hepatitis and eventual death from liver cirrhosis and
hepatocellular carcinoma(3).
In endemic regions, HBV related diseases exert a
heavy toll socio-economically by affecting mainly the
young and economically active age group(4). The demands
on health care resources are also enormous.
It has been  established that most infections in endemic
regions were acquired in childhood(5). It is also known
that prevalence increases with age and transmission occurs
mostly through parenteral and sexual exposure and in
special risk groups such as health care workers (HCWs)
and the sexually active(4). The risk of HBV infection in
HCWs depends on the prevalence of HBV infected patients
that the HCWs are exposed to, and the frequency of
exposure to infected blood and body fluids(6). Among
HCWs, surgeons have the highest risk of HBV infection
from their patients(7). Although it is recognised that
surgeons are at a high risk of acquiring HBV infection
there has been little investigation of this problem in
Nigeria. The aim of this study is to determine the prevalence
of HBV markers in surgeons in Lagos.
MATERIALS AND METHODS
This was a cross-sectional, descriptive study involving 167
surgeons working in three large hospitals in Lagos, Nigeria.
Surgeons in training or in practice were eligible to participate in
this voluntary survey. The control group was made up of 193
administrative staff of the hospitals. The exclusion criteria were
previous history of jaundice, blood transfusion and liver disease.
A questionnaire consisting of demographic data(7), occupational
and non-occupational risk factors to HBV (surgical specialty and
duration of surgical practice, grade, frequency of contact with
blood and body fluids, frequency of needle stick/sharps injuries,
glove tears, types of protective devices used) was completed by
each subject.
Blood sample was obtained from each subject and
centrifuged to separate serum. They were stored frozen at -20°C
at the Central Public Health Laboratory, Lagos until analysed.
The serum samples were coded and screened for HBsAg, antiHBs
and antiHBc by ELISA technique(Murex HBsAg, Murex
Diagnostics England, Antisurase B-96 and Anticorase B-96-
General Biological Corporation Taiwan for antiHBs and antiHBc,
respectively).
The proportions of subjects with HBV serological markers
were analysed . The Chi-square test was applied for comparing
proportions between groups. Differences of p<0.05 were taken
to be statistically significant. Ethical approval for the study was
obtained from the Lagos University Teaching Hospital Ethics
Committee. Informed consent was obtained from each subject,
each assured of maximum confidentiality.
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RESULTS
One hundred and sixty seven surgeons were tested for
serological markers of HBV infection. The male to female
ratio was 121(72.5%) to 46 (27.5%). The mean age was
32.3years and the mean duration of surgical practice was
7.9 years. One hundred and ninety three people made up
the control group of which 132 (68.8%) were male and




Age group (years ) Surgeons (n=167) Controls (n=193)
         20 - 30 38 (22.9%) 59 (30.6%)
         31 - 40 100 (60.2%) 98 (50.8%)
         41 - 50 28 (16.8%) 33 (17.1%)
         51 - 60 1 (0.6%) 3 (1.6%)
Table 2
Frequency of HBV markers in surgeons and controls
HBsAg AntiHBs AntiHBc
+ve -ve +ve -ve +ve -ve
Surgeons
(n=167) 43 124 37 130 103 64
(25.7%) (74.3%) (22.2%) (77.8%) (61.7%)(38.3%)
Controls
(n=193) 29 164 8 185 103 90
(15.0%) (85.0%) (4.1%) (95.9%) (53.4%)(46.6%)
χ2 value 6.43 26.55 2.53
p value 0.01 <0.001 0.11
Table 3
Overall frequency of HBV markers
Surgeons Controls
At least one HBV marker 128 (76.6%) 110 (57.0%)
No HBV marker   39 (23.4%)   83 (43.0%)
Odds Ratio = 2.48
χ2 =15.43
p = 0.0009
The prevalence of HBsAg among the surgeons was
25.7% compared to 15.0% in the control group (p=0.01).
The prevalence of antiHBs was 22.2% in the surgeons and
4.1% in the control (p=0.001) and that of antiHBc was
61.7% in the surgeons compared to 53.4% in the controls
(p= 0.11). At least one HBV marker was found on 76.6%
of the surgeons compared to 57% of the control group
(Table 3). No HBV marker was detected in 23.4% of the
surgeons as against 43% of the control group. The difference
was statistically significant (p=0.0009,  Odds ratio 2.48 at
95% confidence interval).
DISCUSSION
This study showed a higher prevalence of HBV
infection among surgeons than in the general population
in Lagos, Nigeria. Previous studies in the pre-HBV vaccine
era demonstrated an increased risk of HBV infection in
various categories of hospital workers especially
surgeons(7). Goldsmith and colleagues(8) found that
among HCWs, specialties with the highest risk of HBV
infection (29% to 53%) were Surgery, Emergency
Medicine, Infectious Disease Units and Obstetrics and
Gynaecology. Overall, 30% of HCWs were positive for
HBsAg while 27. 5% were antiHBs positive. Olubuyide et
al (9) working in Ibadan, Nigeria showed a 39% frequency
of HBsAg in doctors than in blood donors with 20%
frequency of HBsAg (p< 0.5).The common factor for
those at high risk has been high frequency of contact with
patients’ blood(6) HBV marker prevalence in surgeons in
Lagos was comparable to those of Romieu et al (10) who
found HBsAg seropositivity of 17.8% and antiHBs positive
in 79.2% of hospital workers in Senegal.
Previous studies in Africa have shown that there was
no difference between prevalence of HBV in HCWs and
the general population(4,1l). The variations between these
studies and our study may possibly be due to actual
difference in risk at different hospitals and to difficulty in
controlling for confounding factors not related to
occupation, for example, socio-economic class,
overcrowding, poor hygiene and sexual transmission.
This study, again confirms the previously reported
high prevalence of HBsAg in this part of the world(12),
but unlike those reports, the rates in this study appear
slightly higher. Previous studies employed the radio-
immunoassay (RIA) technique in analysing the serum
samples while ELISA technique was used in this study.
Although ELISA is known to have comparable sensitivity
with RIA, it has been reported to have a lower specificity
due to slightly higher false positive reactions(13). The
higher prevalence of HBsAg could also be that the
prevalence of HBV infection is increasing. This is
particularly so in view of the falling socio-economic
standard in the country.
The prevailing poor economic situation has
compromised standards giving rise to inadequate provision
of barrier devices for the HCWs.
A high rate of HBV exposure (combined HBV marker
frequency) which was found in the control population
(57%), is similar to the findings of Nasidi et al (57.8%) in
blood donors in Lagos(14). The antiHBs prevalence of
22.2% found in the surgeons this study is also similar to
that reported by Goldsmith et al. in Egypt (27.5%). The
antiHBs prevalence in this study was unexpectedly low in
the control group (4.1%). This is much lower than that
reported in previous studies(12,14).
This study shows that surgeons in Nigeria have higher
HBV infection prevalence than the general population.
There is a need for urgent intervention to reduce the rate
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of HBV infection in this high risk group. Also, in view of
the risk of transmission of HBV to patients and the
consequences of its chronic infection, there is a strong
need to consider immunisation of all at risk healthcare
workers in Nigeria as done in the developed countries.
Some studies in Africa(4,11) have suggested that
there was no need to vaccinate HCWs with HBV vaccine
since there was no difference in the prevalence of HBV
markers in HCWs and the general population in these
studies and thus suggested the adoption of universal
precautions (UPs). Although the benefits of UPs may be
significant, the cost of implementing them are enormous.
Doebbeling and Wenzel(15) have estimated that the
UPs cost at least 336 million dollars per year in the USA
to implement and maintain. In addition, adverse exposure
can occur while using protective devices(16).
The high prevalence of HBsAg carrier in developing
countries might therefore justify vaccination of HCWs at
risk. Taiwan and Saudi Arabia have seen the tremendous
impact of a mass programme of HBV immunisation and
the integration of HBV vaccine in the Expanded Programme
of Immunisation (EPI) in controlling HBV infectivity in
the general population(17,18). This is a route which Nigeria
might well consider.
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